Charles, J., Chaperot, L., Hannani, D., Bruder Costa, J., Templier, I., Trabelsi, S., . . . Plumas, J. (2020). An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial. Oncoimmunology.
Citação norma ChicagoCharles, Julie, et al. "An Innovative Plasmacytoid Dendritic Cell Line-based Cancer Vaccine Primes and Expands Antitumor T-cells in Melanoma Patients in a First-in-human Trial." Oncoimmunology 2020.
MLA CitationCharles, Julie, et al. "An Innovative Plasmacytoid Dendritic Cell Line-based Cancer Vaccine Primes and Expands Antitumor T-cells in Melanoma Patients in a First-in-human Trial." Oncoimmunology 2020.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.